MedPath

Safety and efficacy check of Prickly Heat Powder

Not Applicable
Completed
Registration Number
CTRI/2023/05/053031
Lead Sponsor
ITC LIMITED ITC Life Sciences and Technology Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

1. 35 subjects of either gender in the age group of 19 to 50 yrs, with primary symptoms of Miliaria rubra on body (neck/ back / arms).

2. Subjects with no history of having used a similar product during or since 1 week prior to the scheduled study commencement.

3. Subjects who show no skin sensitivity symptoms to the investigational products during skin sensitivity test.

4. Subjects who are willing to abide by study protocol and specific restrictions.

Exclusion Criteria

1. Subjects who have participated in similar kind of investigation in the past four weeks.

2. Subjects having any infection on skin/ nail that could spread or interfere with the test readings / with a known history or current condition of allergy or sensitivity to cosmetic products/ fragrances.

3. Subjects who are undergoing any medical treatment or taking any systemic medicines since 4 weeks prior to study commencement or applying any topical medication in the past 2 weeks prior to study commencement which could compromise the study.

4. Female subjects who are either pregnant or nursing.

5. Subjects with symptoms of Miliaria pustulosa, Miliaria profunda as identified by the dermatologist.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in Miliaria symptoms namely- <br/ ><br>- Eruption size / number / area covered/ Pruritis/ <br/ ><br>Erythema/ Oedema/ Excoriation over baseline. <br/ ><br>Timepoint: Baseline, Day 7, Day 14
Secondary Outcome Measures
NameTimeMethod
Safety and tolerance of a test productTimepoint: Baseline, Day 7, Day 14
© Copyright 2025. All Rights Reserved by MedPath